ArticleVeterinary medicine and science2026
Hyaluronic Acid-Based Photocurable Glue Application as an Alternative Surgical Approach for Corneal Injuries in Canine Patients: A Case Series.
Article in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Effective non-surgical alternatives are required for managing severe corneal injuries in dogs when surgical intervention is not feasible. This case series evaluated the therapeutic potential of hyaluronic acid (HA)-based photocurable glue (HA photoglue, Teratouch-ETM, SNVIA) in three dogs with deep corneal injuries. Case 1 was a 16-year-old Pekingese with systemic disease presenting with a descemetocele. Case 2 was a 14-year-old Maltese with diabetes mellitus and a corneal perforation. Case 3 was a 10-year-old mixed-breed dog with a corneal laceration involving 50 % stromal depth. All cases underwent topical anaesthesia and light sedation. A 20 µL drop of HA photoglue was applied to the lesion and photocrosslinked with short visible light (405 nm, 4.3 s). Applications were repeated during follow-up depending on lesion size and adhesive stability. In Case 1, 16 applications over 9 months maintained corneal integrity and transparency without perforation or inflammation. In Case 2, five sequential applications over 3 months achieved complete re-epithelialisation and stromal remodelling. In Case 3, a single treatment resulted in full epithelial closure by two weeks, and corneal clarity and visual function were fully restored by eight weeks. This case series suggests that HA photoglue may serve as a safe and minimally invasive therapeutic approach for canine corneal injuries, providing mechanical stabilisation and demonstrating clinical potential when conventional surgery is not feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.